Kennedy Capital Management’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-35,283	Closed	-$134K	–	724
2024 Q2	$134K	Buy	35,283 +10,248	+41%	+$39K	﹤0.01%	691
2024 Q1	$119K	Buy	+25,035	New	+$119K	﹤0.01%	717